{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:52:54Z","timestamp":1788807174874,"version":"build-2803163510"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>People with human immunodeficiency virus (HIV, PWH) are at higher risk for visceral adiposity, enhanced inflammation, and cognitive decline than controls who do not have HIV. We previously demonstrated that PWH with lipohypertrophy had a decrease in weight, visceral adipose tissue, and several inflammatory markers after receiving semaglutide, a glucagon-like peptide-1 receptor agonist. Our aim was to investigate the effect of semaglutide on cognitive function in PWH and the possible mediation of this effect by changes in adiposity or inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this randomized, double-blind, placebo-controlled phase 2b clinical trial, PWH on antiretroviral therapy were randomized 1:1 to receive 32 weeks of subcutaneous semaglutide or placebo. The primary outcome was the change in cognitive function at 32 weeks. Secondary measures included changes in body composition and inflammatory markers. Causal mediation analysis assessed semaglutide's direct and indirect effects on Cognivue scores through changes in adiposity and inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>108 participants were included (54 per arm); 65% were non-White, 40% were female, and median age was 53 years. Compared with placebo, PWH on semaglutide significantly increased visuospatial, naming\/language, and delayed recall scores at 32 weeks (P = .01, .05, and .04, respectively). After adjusting for sex and absolute CD4 count, only visuospatial score remained statistically significant (P = .05). Semaglutide's total natural direct effect maintained a positive effect on the visuospatial score while accounting for potential changes in high-sensitivity C-reactive protein and soluble CD163 levels (P = .04).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Semaglutide may have a beneficial impact on visuospatial cognitive function in PWH through its effect on inflammation.<\/jats:p>\n                    <jats:p>Clinical Trials Registration . NCT04019197.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaf577","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:13:45Z","timestamp":1760530425000},"page":"753-761","source":"Crossref","is-referenced-by-count":7,"title":["Effects of Semaglutide on Cognitive Function in People With HIV: A Randomized, Controlled Trial"],"prefix":"10.1093","volume":"82","author":[{"given":"Ornina","family":"Atieh","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Case Western Reserve University , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9008-4066","authenticated-orcid":false,"given":"Joviane","family":"Daher","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Case Western Reserve University , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Abboud","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Saint Joseph University , Beirut ,","place":["Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Case Western Reserve University , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3863-3113","authenticated-orcid":false,"given":"Abdus","family":"Sattar","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Case Western Reserve University , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhony","family":"Baissary","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Case Western Reserve University , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6819-1926","authenticated-orcid":false,"given":"Ziad","family":"Koberssy","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Case Western Reserve University , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Labbato","sequence":"additional","affiliation":[{"name":"Clinical Research Center, University Hospitals Cleveland Medical Center , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison Ross","family":"Eckard","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases, Medical University of South Carolina , Charleston, South Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2690-8888","authenticated-orcid":false,"given":"Grace A","family":"McComsey","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, School of Medicine, Case Western Reserve University , Cleveland, Ohio ,","place":["USA"]},{"name":"Clinical Research Center, University Hospitals Cleveland Medical Center , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"2026052019222962100_ciaf577-B1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-associated neurocognitive disorder","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"2026052019222962100_ciaf577-B2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s13365-017-0590-4","article-title":"Variability in C-reactive protein is associated with cognitive impairment in women living with and without HIV: a longitudinal study","volume":"24","author":"Rubin","year":"2018","journal-title":"J Neurovirol"},{"key":"2026052019222962100_ciaf577-B3","doi-asserted-by":"crossref","first-page":"e35652","DOI":"10.1097\/MD.0000000000035652","article-title":"HIV-related neurocognitive disorders: diagnosis, treatment, and mental health implications: a review","volume":"102","author":"Elendu","year":"2023","journal-title":"Medicine"},{"key":"2026052019222962100_ciaf577-B4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.it.2022.06.003","article-title":"The potential role of HIV-1 latency in promoting neuroinflammation and HIV-1-associated neurocognitive disorder","volume":"43","author":"Sreeram","year":"2022","journal-title":"Trends Immunol"},{"key":"2026052019222962100_ciaf577-B5","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1473-3099(13)70269-X","article-title":"HIV-associated neurocognitive disorder","volume":"13","author":"Clifford","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2026052019222962100_ciaf577-B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-7-79","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study","volume":"7","author":"Lackner","year":"2010","journal-title":"J Neuroinflammation"},{"key":"2026052019222962100_ciaf577-B7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/COH.0000000000000923","article-title":"Neuropathogenesis of acute HIV: mechanisms, biomarkers, and therapeutic approaches","volume":"20","author":"Jia","year":"2025","journal-title":"Curr Opin HIV AIDS"},{"key":"2026052019222962100_ciaf577-B8","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/s41380-022-01619-2","article-title":"Neuroinflammation in HIV-associated depression: evidence and future perspectives","volume":"27","author":"Rakshasa-Loots","year":"2022","journal-title":"Mol Psychiatry"},{"key":"2026052019222962100_ciaf577-B9","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1212\/WNL.0000000000002485","article-title":"Neuroinflammation in treated HIV-positive individuals: a TSPO PET study","volume":"86","author":"Vera","year":"2016","journal-title":"Neurology"},{"key":"2026052019222962100_ciaf577-B10","doi-asserted-by":"crossref","first-page":"e31125","DOI":"10.1097\/MD.0000000000031125","article-title":"Comprehensive assessment of neurocognitive function, inflammation markers, and adiposity in treated HIV and control","volume":"101","author":"Mouchati","year":"2022","journal-title":"Medicine"},{"key":"2026052019222962100_ciaf577-B11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2012.04.010","article-title":"Brain injury caused by HIV protease inhibitors: role of lipodystrophy and insulin resistance","volume":"95","author":"Gupta","year":"2012","journal-title":"Antiviral Res"},{"key":"2026052019222962100_ciaf577-B12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S2213-8587(24)00150-5","article-title":"Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial","volume":"12","author":"Eckard","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026052019222962100_ciaf577-B13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11904-016-0298-8","article-title":"Fat matters: understanding the role of adipose tissue in health in HIV infection","volume":"13","author":"Erlandson","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2026052019222962100_ciaf577-B14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/infdis\/jiw506","article-title":"Monocyte activation is associated with worse cognitive performance in HIV-infected women with virologic suppression","volume":"215","author":"Imp","year":"2017","journal-title":"J Infect Dis"},{"key":"2026052019222962100_ciaf577-B15","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/infdis\/jiy337","article-title":"Normalization of soluble CD163 levels after institution of antiretroviral therapy during acute HIV infection tracks with fewer neurological abnormalities","volume":"218","author":"D\u2019Antoni","year":"2018","journal-title":"J Infect Dis"},{"key":"2026052019222962100_ciaf577-B16","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1017\/S0033291717003130","article-title":"High-sensitivity C-reactive protein and cognitive decline: the English longitudinal study of ageing","volume":"48","author":"Zheng","year":"2018","journal-title":"Psychol Med"},{"issue":"JAN","key":"2026052019222962100_ciaf577-B17","first-page":"305462","article-title":"Association of peripheral interleukin-6 with global cognitive decline in non-demented adults: a meta-analysis of prospective studies","volume":"9","author":"Bradburn","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"2026052019222962100_ciaf577-B18","doi-asserted-by":"crossref","first-page":"ofaf152","DOI":"10.1093\/ofid\/ofaf152","article-title":"The effects of semaglutide on inflammation and immune activation in HIV-associated lipohypertrophy","volume":"12","author":"Funderburg","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"2026052019222962100_ciaf577-B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-024-02237-8","article-title":"Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitus","volume":"23","author":"Grannes","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"2026052019222962100_ciaf577-B20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41380-022-01632-5","article-title":"Selective visuoconstructional impairment following mild COVID-19 with inflammatory and neuroimaging correlation findings","volume":"28","author":"de Paula","year":"2022","journal-title":"Mol Psychiatry"},{"key":"2026052019222962100_ciaf577-B21","doi-asserted-by":"crossref","first-page":"578327","DOI":"10.1016\/j.jneuroim.2024.578327","article-title":"Follow-up of cognitive impairment and inflammatory profile in individuals with mild COVID-19","volume":"389","author":"Souza-Silva","year":"2024","journal-title":"J Neuroimmunol"},{"key":"2026052019222962100_ciaf577-B22","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00125-016-3874-y","article-title":"GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial","volume":"59","author":"Farr","year":"2016","journal-title":"Diabetologia"},{"key":"2026052019222962100_ciaf577-B23","doi-asserted-by":"crossref","first-page":"e133429","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2021","journal-title":"JCI Insight"},{"key":"2026052019222962100_ciaf577-B24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2147\/DDDT.S348055","article-title":"The role of glucagon-like peptide-1 receptor agonists (GLP-1 RA) in diabetes-related neurodegenerative diseases","volume":"16","author":"Cheng","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"2026052019222962100_ciaf577-B25","doi-asserted-by":"crossref","first-page":"1047883","DOI":"10.3389\/fendo.2022.1047883","article-title":"Impact of glucagon-like peptide 1 analogs on cognitive function among patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"13","author":"Luan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026052019222962100_ciaf577-B26","doi-asserted-by":"crossref","first-page":"8661","DOI":"10.1002\/alz.14313","article-title":"Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: target trial emulation using nationwide real-world data in the US","volume":"20","author":"Wang","year":"2024","journal-title":"Alzheimer's Dementia"},{"key":"2026052019222962100_ciaf577-B27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jamaneurol.2025.0360","article-title":"Cardioprotective glucose-lowering agents and dementia risk: a systematic review and meta-analysis","volume":"82","author":"Seminer","year":"2025","journal-title":"JAMA Neurol"},{"key":"2026052019222962100_ciaf577-B28","doi-asserted-by":"crossref","first-page":"20420188231222370","DOI":"10.1177\/20420188231222367","article-title":"Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications","volume":"15","author":"Alharbi","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2026052019222962100_ciaf577-B29","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.3390\/ijms24097789","article-title":"An overview of the cardioprotective effects of novel antidiabetic classes: focus on inflammation, oxidative stress, and fibrosis","volume":"24","author":"Balogh","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026052019222962100_ciaf577-B30","doi-asserted-by":"crossref","first-page":"1379189","DOI":"10.3389\/fcvm.2024.1379189","article-title":"Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis","volume":"11","author":"Masson","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"2026052019222962100_ciaf577-B31","doi-asserted-by":"crossref","first-page":"112578","DOI":"10.1016\/j.physbeh.2019.112578","article-title":"Effects of adiposity and metabolic dysfunction on cognition: a review","volume":"208","author":"Farruggia","year":"2019","journal-title":"Physiol Behav"},{"key":"2026052019222962100_ciaf577-B32","doi-asserted-by":"crossref","first-page":"1160426","DOI":"10.3389\/fmed.2023.1160426","article-title":"The association between regional adiposity, cognitive function, and dementia-related brain changes: a systematic review","volume":"10","author":"Boccara","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"2026052019222962100_ciaf577-B33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/QAI.0000000000000458","article-title":"Abdominal obesity contributes to neurocognitive impairment in HIV infected patients with increased inflammation and immune activation","volume":"68","author":"Sattler","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026052019222962100_ciaf577-B34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3851\/IMP2952","article-title":"Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected men","volume":"20","author":"Lake","year":"2015","journal-title":"Antivir Ther"},{"key":"2026052019222962100_ciaf577-B35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s13365-013-0219-1","article-title":"Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women's Interagency HIV study","volume":"19","author":"Gustafson","year":"2013","journal-title":"J Neurovirol"},{"key":"2026052019222962100_ciaf577-B36","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/cid\/cit748","article-title":"Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy","volume":"58","author":"Funderburg","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2026052019222962100_ciaf577-B37","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1212\/WNL.0b013e31822f0412","article-title":"Minocycline treatment for HIV-associated cognitive impairment","volume":"77","author":"Sacktor","year":"2011","journal-title":"Neurology"},{"key":"2026052019222962100_ciaf577-B38","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1097\/QAD.0000000000004267","article-title":"No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV","volume":"39","author":"Erlandson","year":"2025","journal-title":"AIDS"},{"key":"2026052019222962100_ciaf577-B39","doi-asserted-by":"crossref","first-page":"114187","DOI":"10.1016\/j.bcp.2020.114187","article-title":"Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics","volume":"180","author":"Salameh","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"2026052019222962100_ciaf577-B40","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/WNL.94.15_supplement.1553","article-title":"Superior test-retest reliability of cognitive assessment with Cognivue\u00ae vs SLUMS during an 18-month longitudinal study (1553)","volume":"94","author":"Andrefsky","year":"2020","journal-title":"Neurology"},{"key":"2026052019222962100_ciaf577-B41","article-title":"Neurological sciences and neurosurgery scholars clinical validation of Cognivue\u00ae","volume":"2","author":"Ma","year":"2021","journal-title":"Neurol Sci Neurosurg"},{"key":"2026052019222962100_ciaf577-B42","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/j.jagp.2019.01.124","article-title":"Comparison of the Cognivue\u00ae quantitative assessment tool and SLUMS to classify the risk of cognitive impairment.","volume":"27","author":"Cahn-Hidalgo","year":"2019","journal-title":"Am J Geriatr Psychiatry"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf577\/64714548\/ciaf577.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/5\/753\/64714548\/ciaf577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/5\/753\/64714548\/ciaf577.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:22:36Z","timestamp":1779319356000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/5\/753\/8287292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10,16]]},"published-print":{"date-parts":[[2026,5,20]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf577","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,15]]},"published":{"date-parts":[[2025,10,16]]}}}